A549 |
Human Lung Adenocarcinoma |
AGS |
Gastric Adenocarcinoma |
AMPK |
AMP Activated Protein Kinase |
CACO |
Human Colon Carcinoma |
CCK |
Cell Counting Kit |
CDK |
Cyclin Dependent Kinase |
DAPI |
4′,6-Diamidino-2-Phenylindole |
DCFH-DA |
Dichlorodihydrofluorescein diacetate |
DLA/DAL |
Dalton’s Lymphoma Ascites/Dalton’s Ascites Lymphoma |
DTP |
Developmental Therapeutic Program |
GSH |
Glutathione |
H1299 |
Human Non-Small Cell Lung Cancer |
HCT/HT |
Human Colorectal Adenocarcinoma |
HeLa |
Henrietta Lacks Cervical Cancer |
Hep |
Human Epithelial |
HL |
Human Caucasian Promyelocytic Leukemia |
IC50/EC50
|
Concentration Required to Inhibit/Destroy 50% Cells |
NF-kB
|
Nuclear Factor-Kappa B |
MCF |
Human Breast Adenocarcinoma |
MCL |
Myeloid Cell Leukemia |
MDA-MB |
M. D. Anderson Metastasis Breast Cancer |
MMP |
Matrix Metallopeptidase |
MST |
Mean Survival Time |
MTT |
3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide |
OSA |
Osteosarcoma |
PARP |
PolyADP-ribosepolymerase |
PC |
Prostate Cancer |
PKC |
Protein Kinase C |
SRB |
Sulforhodamine B |
STAT |
Signal Transducer and Activator of Transcription |
T47D |
Ductal Epithelial Breast Tumor |
TBE |
Trypan Blue Exclusion |
THP |
Human Acute Monocytic Leukemia |
VEGF |
Vascular Endothelial Growth Factor |
Vero |
Verda Reno |
WM |
Malignant Melanoma |
WST |
Water Soluble Tetrazolium |
XTT |
Cell Proliferation Kit II |